(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 43.90%-428.63K | -2,727.36%-181.31K | 27.77%-133.37K | 94.42%-16.57K | 66.38%-97.37K | 24.58%-764.05K | 101.38%6.9K | 37.28%-184.63K | -1,218.18%-296.72K | -17.60%-289.6K |
Net income from continuing operations | 31.69%-676.67K | -43.24%-325.28K | 33.87%-107.83K | 60.34%-102.14K | 58.77%-141.42K | -1.61%-990.65K | -68.16%-227.09K | 63.09%-163.05K | -2,001.91%-257.56K | 16.70%-342.96K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -44.83%-33.37K | ---18.32K | --0 | --0 | ---15.05K |
Depreciation and amortization | -8.35%32.75K | -8.83%8.17K | -10.34%8.17K | -10.49%8.17K | -3.44%8.23K | -63.77%35.73K | 2.35%8.97K | -70.92%9.11K | -71.03%9.13K | -68.44%8.53K |
Asset impairment expenditure | --0 | --0 | --0 | ---- | ---- | -8.81%122.17K | --112.64K | --0 | ---- | ---- |
Unrealized gains and losses of investment securities | -72.93%21.08K | 91.55%-2.1K | -287.35%-20.57K | 8,664.05%29.01K | -83.87%14.75K | 316.14%77.86K | -5.51%-24.87K | -76.88%10.98K | 100.76%331 | 650.71%91.42K |
Remuneration paid in stock | 330.42%38.02K | --60.52K | --0 | ---- | ---- | -117.41%-16.5K | --0 | --0 | ---- | ---- |
Deferred tax | 70.19%-25.3K | ---25.3K | --0 | --0 | --0 | 5.85%-84.86K | --0 | 82.45%-4.33K | -3.96%-52.49K | -116.14%-28.04K |
Other non cashItems | -3,655.76%-9.89K | -23,266.67%-10.43K | -318.06%-903 | 303.01%669 | 173.50%774 | 100.07%278 | 100.01%45 | -102.04%-216 | 101.79%166 | 32.24%283 |
Change In working capital | 52.75%191.38K | -27.28%113.1K | 63.37%-13.69K | 558.28%70.4K | 707.95%21.58K | -20.83%125.29K | 274.97%155.53K | 21.68%-37.38K | -84.11%10.69K | -103.65%-3.55K |
-Change in receivables | -137.14%-30.34K | -108.56%-9.34K | -39.65%-13.28K | -293.07%-3.92K | 77.51%-3.8K | 119.34%81.69K | 240.97%109.11K | -140.46%-9.51K | 93.28%-996 | -393.75%-16.92K |
-Change in prepaid assets | -194.25%-39.94K | 1,005.17%9.45K | -413.91%-52.18K | -69.12%7.83K | -445.88%-5.04K | -42.89%42.38K | 63.42%-1.04K | 300.39%16.62K | 2.40%25.35K | -96.98%1.46K |
-Change in payables and accrued expense | 21,383.17%261.67K | 138.10%112.99K | 216.36%51.77K | 586.82%66.49K | 155.36%30.42K | -97.40%1.22K | 284.88%47.46K | 40.97%-44.49K | -123.80%-13.66K | -77.30%11.91K |
Interest paid (cash flow from operating activities) | ---- | ---- | ---- | -987.50%-174 | -467.70%-1.28K | ---- | ---- | ---- | 99.84%-16 | 49.33%-226 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 43.90%-428.63K | -2,727.36%-181.31K | 27.77%-133.37K | 94.42%-16.57K | 66.38%-97.37K | 24.58%-764.05K | 101.38%6.9K | 37.28%-184.63K | -1,218.18%-296.72K | -17.60%-289.6K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -261.29%-8.82K | 0 | -126.00%-6.59K | -631.16%-3.51K | 102.64%1.28K | -98.99%5.47K | -95.35%27.98K | 321.33%25.34K | -91.57%661 | 16.77%-48.51K |
Net PPE purchase and sale | 78.03%-10.27K | --0 | ---6.59K | -671.32%-3.69K | --0 | -109.12%-46.76K | --0 | --0 | 129.93%645 | 19.28%-47.41K |
Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 70.61%43.44K | 6.61%27.15K | --0 | --0 | --16.3K |
Interest received (cash flow from investment activities) | 3.11%1.46K | --0 | --0 | 987.50%174 | 467.70%1.28K | -6.55%1.41K | 109.16%829 | 202.65%342 | -99.84%16 | -49.33%226 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | --7.37K | --0 | --25K | --0 | ---17.63K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -261.29%-8.82K | --0 | -126.00%-6.59K | -631.16%-3.51K | 102.64%1.28K | -98.99%5.47K | -95.35%27.98K | 321.33%25.34K | -91.57%661 | 16.77%-48.51K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,622.65%380.82K | 2,597.26%151.03K | 4,162.43%241.88K | 15.96%-6.05K | -4.08%-6.05K | -102.20%-25.01K | -4.95%-6.05K | 43.18%-5.95K | 20.74%-7.2K | -100.50%-5.81K |
Net issuance payments of debt | -3.25%-24.49K | -3.72%-6.27K | -2.84%-6.12K | -2.39%-6.05K | -4.08%-6.05K | 20.81%-23.72K | -4.95%-6.05K | 43.18%-5.95K | 28.05%-5.91K | -5.60%-5.81K |
Net common stock issuance | --425K | --170K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other financing activities | -1,426.59%-19.69K | ---12.69K | ---- | ---- | ---- | 98.73%-1.29K | --0 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,622.65%380.82K | 2,597.26%151.03K | 4,162.43%241.88K | 15.96%-6.05K | -4.08%-6.05K | -102.20%-25.01K | -4.95%-6.05K | 43.18%-5.95K | 20.74%-7.2K | -100.50%-5.81K |
Net cash flow | ||||||||||
Beginning cash position | -71.42%313.54K | 0.87%287.19K | -58.82%185.27K | -71.93%211.4K | -71.42%313.54K | 152.03%1.1M | -71.54%284.71K | -65.83%449.96K | -41.68%753.21K | 152.03%1.1M |
Current changes in cash | 92.77%-56.63K | -205.03%-30.28K | 161.68%101.92K | 91.38%-26.13K | 70.30%-102.14K | -218.40%-783.6K | -70.19%28.83K | 47.76%-165.25K | -1,298.60%-303.26K | -140.17%-343.92K |
End cash Position | -18.06%256.91K | -18.06%256.91K | 0.87%287.19K | -58.82%185.27K | -71.93%211.4K | -71.42%313.54K | -71.42%313.54K | -71.54%284.71K | -65.83%449.96K | -41.68%753.21K |
Free cash from | 45.87%-438.9K | -2,727.36%-181.31K | 24.20%-139.96K | 93.16%-20.26K | 71.11%-97.37K | 26.32%-810.82K | 101.34%6.9K | 39.65%-184.63K | -1,314.37%-296.08K | -10.50%-337.01K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.